dna pairing
Recently Published Documents


TOTAL DOCUMENTS

69
(FIVE YEARS 0)

H-INDEX

25
(FIVE YEARS 0)

2020 ◽  
Vol 295 (24) ◽  
pp. 8186-8194 ◽  
Author(s):  
Fengshan Liang ◽  
Adam S. Miller ◽  
Caroline Tang ◽  
David Maranon ◽  
Elizabeth A. Williamson ◽  
...  

USP1-associated factor 1 (UAF1) is an integral component of the RAD51-associated protein 1 (RAD51AP1)–UAF1-ubiquitin-specific peptidase 1 (USP1) trimeric deubiquitinase complex. This complex acts on DNA-bound, monoubiquitinated Fanconi anemia complementation group D2 (FANCD2) protein in the Fanconi anemia pathway of the DNA damage response. Moreover, RAD51AP1 and UAF1 cooperate to enhance homologous DNA pairing mediated by the recombinase RAD51 in DNA repair via the homologous recombination (HR) pathway. However, whereas the DNA-binding activity of RAD51AP1 has been shown to be important for RAD51-mediated homologous DNA pairing and HR-mediated DNA repair, the role of DNA binding by UAF1 in these processes is unclear. We have isolated mutant UAF1 variants that are impaired in DNA binding and tested them together with RAD51AP1 in RAD51-mediated HR. This biochemical analysis revealed that the DNA-binding activity of UAF1 is indispensable for enhanced RAD51 recombinase activity within the context of the UAF1–RAD51AP1 complex. In cells, DNA-binding deficiency of UAF1 increased DNA damage sensitivity and impaired HR efficiency, suggesting that UAF1 and RAD51AP1 have coordinated roles in DNA binding during HR and DNA damage repair. Our findings show that even though UAF1's DNA-binding activity is redundant with that of RAD51AP1 in FANCD2 deubiquitination, it is required for efficient HR-mediated chromosome damage repair.


Blood ◽  
2019 ◽  
Vol 134 (Supplement_1) ◽  
pp. 2497-2497
Author(s):  
Fengshan Liang ◽  
Adam S Miller ◽  
Carolilne Tang ◽  
Patrick Sung ◽  
Gary M. Kupfer

Background: In the Fanconi anemia (FA) DNA repair pathway, DNA damage induces the mono-ubiquitination of the FANCI-FANCD2 (ID2) heterodimer by the FA core complex through its inherent E3 ligase activity. The timely deubiquitination of ID2 by USP1-UAF1 deubiquitinase complex is also critically important for the FA DNA repair. UAF1 has a DNA binding activity, which is required for FANCD2 deubiquitination. UAF1 also enhances RAD51-mediated homologous DNA pairing in a manner that is dependent on complex formation with RAD51AP1. UAF1 deficient cells are impaired for DNA repair by homologous recombination (HR).The biochemical and cellular functions of UAF1 DNA binding activity in HR remain elusive. Methods:UAF1 wild type and DNA binding mutant proteins were purified and used to define its biochemical properties in HR. In vitroD-loop formation and synaptic complex assembly assay were performed to discover the DNA binding of UAF1 in RAD51 recombinase enhancement. U2OS-DR-GFP cell lines with impaired UAF1 or RAD51AP1DNA binding were generated to examine HR efficiency and DNA damage resistance. Results:UAF1 preferentially binds an HR-intermediate-like DNA substrate (D-loop, Fig.1). The DNA binding deficient mutant of UAF1 is unable to stimulate RAD51AP1 promotion of RAD51-mediated D-loop (Fig. 2) and the ability to recruit homologous DNA to form the presynaptic complex formation in HR (Fig. 3). In cells, the UAF1 DNA-binding mutant is compromised for the ability to repair DNA damage and to implement HR (Fig. 4). Such activity correlates with the ability to confer resistance to DNA cross linking agents such as mitomycin C (Fig. 4). The DNA binding of UAF1 and RAD51AP1 have a coordinated role in HR-directed DNA damage repair (Fig. 5). Conclusions: UAF1 DNA binding activity is indispensable for its function in enhancing RAD51-mediated homologous DNA pairing within the context of the UAF1-RAD51AP1 complex. UAF1 DNA binding deficiency causes DNA damage sensitivity and impairs HR efficiency in cells. Translational Applicability:Our findings reveal a critical role of UAF1 DNA binding in DNA repair and genome maintenance. The identification of UAF1's role in repair will enable targeted efforts to improve molecular approaches for FA therapy. Disclosures No relevant conflicts of interest to declare.


Nature ◽  
2017 ◽  
Vol 550 (7676) ◽  
pp. 360-365 ◽  
Author(s):  
Weixing Zhao ◽  
Justin B. Steinfeld ◽  
Fengshan Liang ◽  
Xiaoyong Chen ◽  
David G. Maranon ◽  
...  
Keyword(s):  

2016 ◽  
Vol 45 (2) ◽  
pp. 711-725 ◽  
Author(s):  
Andrew A. Kelso ◽  
Steven D. Goodson ◽  
Leah E. Watts ◽  
LeAnna L. Ledford ◽  
Sarah M. Waldvogel ◽  
...  
Keyword(s):  

2016 ◽  
Vol 44 (13) ◽  
pp. 6363-6376 ◽  
Author(s):  
Jiangguo Lin ◽  
Preston Countryman ◽  
Haijiang Chen ◽  
Hai Pan ◽  
Yanlin Fan ◽  
...  

Cell Reports ◽  
2016 ◽  
Vol 15 (10) ◽  
pp. 2118-2126 ◽  
Author(s):  
Fengshan Liang ◽  
Simonne Longerich ◽  
Adam S. Miller ◽  
Caroline Tang ◽  
Olga Buzovetsky ◽  
...  
Keyword(s):  

PLoS ONE ◽  
2015 ◽  
Vol 10 (9) ◽  
pp. e0139399 ◽  
Author(s):  
Andrew A. Kelso ◽  
Amanda F. Say ◽  
Deepti Sharma ◽  
LeAnna L. Ledford ◽  
Audrey Turchick ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document